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Of adipocytes and macrophages 
Although a link between body weight, obesity and cardiovascular risk is generally accepted, 
the right way to assess and correlate abdominal fat content to cardiovascular risk factors and 
mortality rates is still being analyzed and debated in the scientific field1, 2. Nonetheless, 
epidemiological studies revealed that abdominal obesity is positively correlated with various 
cardiovascular risk factors, including systolic blood pressure and triglycerides levels, in adult 
man and woman as well as in obese children3-6. Moreover, recent studies using computed 
tomography measured radiodensity demonstrated that the density and hence quality of a 
specific adipose tissue may be more informative and sensitive to predict cardiovascular risk 
compared to fat volume and quantity7-9.  
In 1993 the group of Bruce Spiegelman published an important study in which they 
demonstrated that the adipose tissue directly contributes to systemic inflammation by 
secreting a pro-inflammatory cytokine, thereby linking obesity to insulin resistance and 
diabetes10. Follow up studies demonstrated that the adipose tissue plays important functions 
in metabolism and inflammation via secretion of various adipokines, including hormones and 
inflammatory cytokines. In 2003 two different groups showed that a large contribution of the 
inflammatory state in adipose tissue is attributable to adipose tissue macrophages (ATMs)11, 
12. 
 
Macrophage polarization in adipose tissue 
ATMs derive from blood monocytes, and likely infiltrate the adipose tissue as part on an 
inflammatory response13. Depending on the immune response and environment, 
macrophages can polarize into different subtypes, ranging from pro-inflammatory to anti-
inflammatory macrophages14. This polarization is dependent on the interaction with other 
immune cells, such as T helper cells, but also affected by dietary stimuli. An interesting study 
demonstrated that leptin-deficient mast cells switch ATMs from a pro- to an anti-inflammatory 
polarization without altering T cell differentiation15. Importantly, dietary cholesterol promotes 
atherosclerosis and ATM accumulation in atherosclerotic mouse models16, 17. Bile acids can 
also affect the function of ATMs, and pharmacological activation of a bile acid receptor 
reduced the expression of chemokines in ATMs and prevented atherosclerosis18, 19. 
 
Adipose tissue macrophage polarization and cardiovascular risk 
In a new study Ivana Lesna and colleagues analyzed the association between different ATM 
populations in subcutaneous (SCAT) and visceral (VAT) white adipose tissues and 
cardiovascular risk factors (reference). VAT was acquired during cleansing of a kidney, either 
obtained by transplantation from a living kidney donor or during a peripheral arterial tree 
reconstruction from patients with peripheral arterial disease. SCAT was acquired from similar 
sites in both groups. 
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The ATMs were divided into different polarization groups, ranging from pro- to anti-
inflammatory states. In the VAT the authors noted a positive correlation between pro-
inflammatory ATMs and age, male sex, and hypercholesterolemia. Transitional ATMs, i.e. 
macrophages expressing both pro- and anti-inflammatory markers, were also increased in 
hypercholesterolemia, while the content of anti-inflammatory ATMs was reduced. Importantly, 
statin treatment reversed the enhanced accumulation of pro-inflammatory and transitional 
ATMs; which is in line with previous studies demonstrating that statins exerts anti-
inflammatory functions in macrophages20-23. Notably, the authors did not observe any 
changes in ATM populations in the VAT related to obesity. However, more pro-inflammatory 
and less anti-inflammatory macrophages were observed in SCAT of obese patients (Figure). 
This is rather surprising since VAT has a stronger association with metabolic risk factors24. 
However, adipocytes and other immune cells also contribute to the overall effect of adipose 
tissues on cardiovascular risk. 
 
Future perspective 
The clinical relevance of ATMs with regards to cardiovascular disease remains unclear. Most 
likely these macrophages exert their major cardiovascular effects indirectly via paracrine and 
endocrine signaling to regulate metabolic and inflammatory processes in other tissues. A 
recent study demonstrated that ATMs secrete miRNA-containing exosomes, which in turn 
affect glucose tolerance and insulin sensitivity25. It will be very interesting to determine if the 
miRNAs secreted by these ATMs also exert direct cardiovascular effects. 
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Figure. Scheme illustrating changes in ATM polarization in different patients. SCAT, 
subcutaneous adipose tissue; VAT, visceral adipose tissue; parenthesis displays a trend; 
aged, ≥ 51 years. 
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